Rengin Çetin Güvenç

Rengin Çetin Güvenç

Auto-generated profile, based on publicly available information

Rengin Çetin Güvenç

Department of Cardiology, Istanbul Okan University , Tepeoren District Tuzla Campus, 34959 Istanbul

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2020 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
EPEsra Poyraz
Esra Poyraz
RGRengin Çetin Güvenç
Rengin Çetin Güvenç
FCFatma Can
Fatma Can

23 June 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
ANAbdulrahman Naser
Abdulrahman Naser
KIKhagani Isgandarov
Khagani Isgandarov
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
RGRengin Çetin Güvenç
Rengin Çetin Güvenç
MŞMüslüm Şahin
Müslüm Şahin
Resumo Fundamentos A determinação precisa do colesterol de lipoproteína de baixa densidade (LDL-C) é importante para se alcançar concentrações de LDL-C recomendadas por diretrizes e para reduzir resultados cardiovasculares adversos em pacientes diabéticos. A equação de Friedewald comumente usada (LDL-Cf) produz resultados imprecisos em pacientes diabéticos devido a dislipidemia diabética associada. Recentemente, duas novas equações – Martin/Hopkins (LDL-CMH) e Sampson (LDL-Cs) – foram desenvolvidas para melhorar a precisão da estimativa de LDL-C, mas os dados são insuficientes para sugerir a [...] Resumo Fundamentos A determinação precisa do colesterol de lipoproteína de baixa densidade (LDL-C) é importante para se alcançar concentrações de LDL-C recomendadas por diretrizes e para reduzir resultados cardiovasculares adversos em pacientes diabéticos. A equação de Friedewald comumente usada (LDL-Cf) produz resultados imprecisos em pacientes diabéticos devido a dislipidemia diabética associada. Recentemente, duas novas equações – Martin/Hopkins (LDL-CMH) e Sampson (LDL-Cs) – foram desenvolvidas para melhorar a precisão da estimativa de LDL-C, mas os dados são insuficientes para sugerir a

1 January 2020 in Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
RGRengin Çetin Güvenç
Rengin Çetin Güvenç
EAEmre Aruğaslan
Emre Aruğaslan
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
FKFatma ÖZPAMUK KARADENİZ
Fatma ÖZPAMUK KARADENİZ
HKHülya Kaşıkçıoğlu
Hülya Kaşıkçıoğlu
NÇNeşe Çam
Neşe Çam
Güvenç RÇ, et al. J Cardiovasc Imaging. 2019 Sep;28:e57. https://doi.org/10.4250/jcvi.2020.0038

28 August 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
RGRengin Çetin Güvenç
Rengin Çetin Güvenç
AAAbdullah Ayar Al Arfaj
Abdullah Ayar Al Arfaj
HRHola Razouk
Hola Razouk
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
Coronary artery aneurysms (CAAs) are frequent entities that are encountered in up to 8% of patients undergoing coronary imaging. The most frequent cause of CAAs is atherosclerotic “positive remodeling” of coronary arteries, while congenital, inflammatory, and traumatic etiologies could also be seen. Aneurysms serve as foci for thrombus formation, which may occlude the aneurysmatic segment or embolize distally. Rupture of an aneurysm is a rare yet potentially catastrophic complication of a CAA. Most aneurysms can be managed medically, while percutaneous exclusion of an aneurysm from coronary circulation is appropriate for CAAs that are prone to rupture or thrombosis. Surgical correction remains the ultimate option for patients who are not amenable to percutaneous management or those with a compelling indication for surgery. This review summarizes the available knowledge on the nomenclature, classification, pathophysiology, diagnosis, and management of CAAs, with a particular emphasis on treatment strategies to mitigate the risks associated with CAAs.

26 August 2023 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
RGRengin Çetin Güvenç
Rengin Çetin Güvenç
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
MAMehmet Ata Akıl
Mehmet Ata Akıl
LBLütfü Bekar
Lütfü Bekar
MVMustafa Gökhan Vural
Mustafa Gökhan Vural
MYMehmet Birhan Yılmaz
Mehmet Birhan Yılmaz

4 April 2024 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
RGRengin Çetin Güvenç
Rengin Çetin Güvenç
TGTolga Sinan Güvenç
Tolga Sinan Güvenç
MÇMert Efe Çağlar
Mert Efe Çağlar
AAAbdullah Ayar Al Arfaj
Abdullah Ayar Al Arfaj
ABAilin Behrad
Ailin Behrad
MYMehmet Birhan Yılmaz
Mehmet Birhan Yılmaz